Intensity Therapeutics, Inc.
INTSNasdaqCIK 1567264HealthcareFiscal year ends Dec 31
Reports and events: 83 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1107:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000061 |
| 2026-08-1107:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001567264-26-000059 |
| 2026-06-1616:15 ET | 8-K | 5.07 Shareholder vote results | 0001567264-26-000049 |
| 2026-05-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000047 |
| 2026-05-0716:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001567264-26-000046 |
| 2026-04-3016:06 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001567264-26-000035 |
| 2026-03-2716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000025 |
| 2026-03-2716:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001567264-26-000024 |
| 2026-03-2316:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000021 |
| 2026-03-0608:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000014 |
| 2026-03-0508:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-26-000011 |
| 2026-02-1316:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-26-000007 |
| 2025-12-0507:33 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001567264-25-000111 |
| 2025-12-0407:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000109 |
| 2025-11-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000104 |
| 2025-11-0616:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001567264-25-000103 |
| 2025-10-3116:54 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-047855 |
| 2025-10-2316:02 ET | 8-K | 5.07 Shareholder vote results | 0001567264-25-000096 |
| 2025-09-1016:04 ET | 8-K | 8.01 Other events | 0001567264-25-000093 |
| 2025-09-0908:37 ET | DEF 14A | Proxy statementPeriod 2025-09-09 | 0001567264-25-000090 |
| 2025-08-1216:33 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000081 |
| 2025-08-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000078 |
| 2025-08-0716:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001567264-25-000077 |
| 2025-08-0416:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001567264-25-000071 |
| 2025-07-1816:18 ET | 8-K | 5.07 Shareholder vote results | 0001567264-25-000069 |
| 2025-06-1316:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-031311 |
| 2025-06-0617:05 ET | 8-K | 3.01 Delisting notice | 0001567264-25-000056 |
| 2025-06-0216:01 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001567264-25-000050 |
| 2025-05-2016:05 ET | 8-K | 3.01 Delisting notice | 0001567264-25-000042 |
| 2025-05-1316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000040 |
| 2025-05-1316:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001567264-25-000039 |
| 2025-04-2517:24 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-020057 |
| 2025-04-2408:01 ET | S-1/A | Registration statement, amended | 0001628280-25-019491 |
| 2025-04-2320:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-018908 |
| 2025-04-2217:23 ET | S-1 | Registration statement | 0001628280-25-018892 |
| 2025-03-1316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-25-000011 |
| 2025-03-1316:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001567264-25-000010 |
| 2024-12-1316:00 ET | S-1 | Registration statement | 0001628280-24-051180 |
| 2024-11-2221:43 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-048910 |
| 2024-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-24-000053 |
| 2024-11-1316:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001567264-24-000052 |
| 2024-10-2316:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001567264-24-000045 |
| 2024-08-0816:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-24-000042 |
| 2024-08-0816:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001567264-24-000041 |
| 2024-07-1716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001567264-24-000035 |
| 2024-07-0316:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-031098 |
| 2024-06-0416:05 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001567264-24-000031 |
| 2024-05-2416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001567264-24-000021 |
| 2024-05-1516:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001567264-24-000017 |
| 2024-05-1016:00 ET | 8-K | 1.01 Entry into a material agreement | 0001567264-24-000013 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.